MicroRNA involvement in osteosarcoma

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Kobayashi, Eisuke ^a   Hornicek, Francis J ^a   Duan, Zhenfeng ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; HISTONE DEACETYLASE 4; IFOSFAMIDE; MAMMALIAN TARGET OF RAPAMYCIN; METHOTREXATE; MICRORNA; MICRORNA 132; MICRORNA 135B; MICRORNA 140; MICRORNA 143; MICRORNA 150; MICRORNA 192; MICRORNA 193A; MICRORNA 199A; MICRORNA 21; MICRORNA 215; MICRORNA 31; MICRORNA 34A; MICRORNA 370; MICRORNA 542; MICRORNA 652; MICRORNA 92A; PROTEIN BCL X; PROTEIN MCL 1; PROTEIN P53; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DISTANT METASTASIS; DNA DAMAGE; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MESENCHYMAL STEM CELL; MUSCLE DEVELOPMENT; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RHABDOMYOSARCOMA; RNA ANALYSIS; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

EID: 84861090747     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/359739     Document Type: Review

References (69)

1. Geller D. S., Gorlick R., Osteosarcoma: a review of diagnosis, management, and treatment strategies Clinical Advances in Hematology and Oncology 2010 8 10 705 718
2. Bielack S. S., Kempf-Bielack B., Delling G., Exner G. U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Wemer M., Winkelmann W., Zoubek A., Jrgens H., Winkler K., Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols Journal of Clinical Oncology 2002 20 3 776 790 (Pubitemid 34111386)
3. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 2 281 297
4. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 1993 75 5 843 854 (Pubitemid 24014542)
5. Berezikov E., Guryev V., Van De Belt J., Wienholds E., Plasterk R. H. A., Cuppen E., Phylogenetic shadowing and computational identification of human microRNA genes Cell 2005 120 1 21 24 (Pubitemid 40094599)
6. Croce C. M., Causes and consequences of microRNA dysregulation in cancer Nature Reviews Genetics 2009 10 10 704 714
7. Heneghan H. M., Miller N., Kerin M. J., MiRNAs as biomarkers and therapeutic targets in cancer Current Opinion in Pharmacology 2010 10 5 543 550
8. Nana-Sinkam S. P., Croce C. M., MicroRNAs as therapeutic targets in cancer Translational Research 2011 157 4 216 225
9. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers Nature 2005 435 7043 834 838 (Pubitemid 40839735)
10. Taulli R., Bersani F., Foglizzo V., Linari A., Vigna E., Ladanyi M., Tuschl T., Ponzetto C., The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation Journal of Clinical Investigation 2009 119 8 2366 2378
11. Duan Z., Choy E., Petur Nielsen G., Rosenberg A., Iafrate J., Yang C., Schwab J., Mankin H., Xavier R., Hornicek F. J., Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in met expression Journal of Orthopaedic Research 2010 28 6 746 752
12. Naka T., Iwamoto Y., Shinohara N., Ushijima M., Chuman H., Tsuneyoshi M., Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors Modern Pathology 1997 10 8 832 838 (Pubitemid 27374855)
13. Ostroumov E., Hunter C. J., Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein Spine 2008 33 25 2774 2780
14. Subramanian S., Lui W. O., Lee C. H., Espinosa I., Nielsen T. O., Heinrich M. C., Corless C. L., Fire A. Z., Van De Rijn M., MicroRNA expression signature of human sarcomas Oncogene 2008 27 14 2015 2026 (Pubitemid 351442735)
15. Sarver A. L., Phalak R., Thayanithy V., Subramanian S., S-MED: sarcoma microRNA Expression Database Laboratory Investigation 2010 90 5 753 761
16. Kansara M., Thomas D. M., Molecular pathogenesis of osteosarcoma DNA and Cell Biology 2007 26 1 1 18 (Pubitemid 46219587)
17. Tang N., Song W. X., Luo J., Haydon R. C., He T. C., Osteosarcoma development and stem cell differentiation Clinical Orthopaedics and Related Research 2008 466 9 2114 2130
18. Siclari V. A., Qin L., Targeting the osteosarcoma cancer stem cell Journal of Orthopaedic Surgery and Research 2010 5 1, article 78
19. Liu C., Tang D. G., MicroRNA regulation of cancer stem cells Cancer Research 2011 71 18 5950 5954
20. Maire G., Martin J. W., Yoshimoto M., Chilton-MacNeill S., Zielenska M., Squire J. A., Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma Cancer Genetics 2011 204 3 138 146
21. Lulla R. R., Costa F. F., Bischof J. M., Identification of differentially expressed micrornas in osteosarcoma Sarcoma 2011 2011 6
22. Schaap-Oziemlak A. M., Raymakers R. A., Bergevoet S. M., Gilissen C., Jansen B. J. H., Adema G. J., Kgler G., Sage C. L., Agami R., Van Der Reijden B. A., Jansen J. H., MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells Stem Cells and Development 2010 19 6 877 885
23. Stabley D. L., Kamara D., Holbrook J., Digital gene expression of mirna in osteosarcoma xenografts: finding biological relevance in mirna high throughput sequencing data Journal of Biomolecular Techniques 2010 21 3, supplement, article S25
24. Marina N., Gebhardt M., Teot L., Gorlick R., Biology and therapeutic advances for pediatric osteosarcoma Oncologist 2004 9 4 422 441 (Pubitemid 39014554)
25. Ta H. T., Dass C. R., Choong P. F. M., Dunstan D. E., Osteosarcoma treatment: state of the art Cancer and Metastasis Reviews 2009 28 1-2 247 263
26. Hauben E. I., Arends J., Vandenbroucke J. P., van Asperen C. J., Van Marck E., Hogendoorn P. C. W., Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma European Journal of Human Genetics 2003 11 8 611 618 (Pubitemid 37038776)
27. Hermeking H., p53 enters the MicroRNA world Cancer Cell 2007 12 5 414 418 (Pubitemid 350046413)
28. Hermeking H., The miR-34 family in cancer and apoptosis Cell Death and Differentiation 2010 17 2 193 199
29. Lynam-Lennon N., Maher S. G., Reynolds J. V., The roles of microRNA in cancer and apoptosis Biological Reviews 2009 84 1 55 71
30. He C., Xiong J., Xu X., Lu W., Liu L., Xiao D., Wang D., Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples Biochemical and Biophysical Research Communications 2009 388 1 35 40
31. Braun C. J., Zhang X., Savelyeva I., Wolff S., Moll U. M., Schepeler T., rntoft T. F., Andersen C. L., Dobbelstein M., p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest Cancer Research 2008 68 24 10094 10104
32. Creighton C. J., Fountain M. D., Yu Z., Nagaraja A. K., Zhu H., Khan M., Olokpa E., Zariff A., Gunaratne P. H., Matzuk M. M., Anderson M. L., Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers Cancer Research 2010 70 5 1906 1915
33. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szsz A. M., Wang Z. C., Brock J. E., Richardson A. L., Weinberg R. A., A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis Cell 2009 137 6 1032 1046
34. Ferguson W. S., Goorin A. M., Current treatment of osteosarcoma Cancer Investigation 2001 19 3 292 315 (Pubitemid 32374371)
35. Kobayashi E., Masuda M., Nakayama R., Ichikawa H., Satow R., Shitashige M., Honda K., Yamaguchi U., Shoji A., Tochigi N., Morioka H., Toyama Y., Hirohashi S., Kawai A., Yamada T., Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma Molecular Cancer Therapeutics 2010 9 3 535 544
36. Chan J. A., Krichevsky A. M., Kosik K. S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells Cancer Research 2005 65 14 6029 6033 (Pubitemid 40994386)
37. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S. T., Patel T., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 2007 133 2 647 658 (Pubitemid 47187346)
38. Asangani I. A., Rasheed S. A. K., Nikolova D. A., Leupold J. H., Colburn N. H., Post S., Allgayer H., MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 2008 27 15 2128 2136 (Pubitemid 351485639)
39. Zhu S., Si M. L., Wu H., Mo Y. Y., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) Journal of Biological Chemistry 2007 282 19 14328 14336 (Pubitemid 47100416)
40. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y. Y., MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Research 2008 18 3 350 359 (Pubitemid 351333899)
41. Ziyan W., Shuhua Y., Xiufang W., Xiaoyun L., MicroRNA-21 is involved in osteosarcoma cell invasion and migration Medical Oncology 2011 28 4 1469 1474
42. Kang H. G., Kim H. S., Kim K. J., Oh J. H., Lee M. R., Seol S. M., Han I., RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness Journal of Orthopaedic Research 2007 25 5 696 702 (Pubitemid 46730522)
43. Duan Z., Choy E., Harmon D., Liu X., Susa M., Mankin H., Hornicek F., MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration Molecular Cancer Therapeutics 2011 10 8 1337 1345
44. Fornari F., Milazzo M., Chieco P., Negrini M., Calin G. A., Grazi G. L., Pollutri D., Croce C. M., Bolondi L., Gramantieri L., MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells Cancer Research 2010 70 12 5184 5193
45. Ichimi T., Enokida H., Okuno Y., Kunimoto R., Chiyomaru T., Kawamoto K., Kawahara K., Toki K., Kawakami K., Nishiyama K., Tsujimoto G., Nakagawa M., Seki N., Identification of novel microRNA targets based on microRNA signatures in bladder cancer International Journal of Cancer 2009 125 2 345 352
46. Osaki M., Takeshita F., Sugimoto Y., Kosaka N., Yamamoto Y., Yoshioka Y., Kobayashi E., Yamada T., Kawai A., Inoue T., Ito H., Oshimura M., Ochiya T., MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression Molecular Therapy 2011 19 6 1123 1130
47. Zhang H., Cai X., Wang Y., Tang H., Tong D., Ji F., microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 Oncology Reports 2010 24 5 1363 1369
48. Michael M. Z., O'Connor S. M., Van Holst Pellekaan N. G., Young G. P., James R. J., Reduced accumulation of specific microRNAs in colorectal neoplasia Molecular Cancer Research 2003 1 12 882 891 (Pubitemid 37288707)
49. Porkka K. P., Pfeiffer M. J., Waltering K. K., Vessella R. L., Tammela T. L. J., Visakorpi T., MicroRNA expression profiling in prostate cancer Cancer Research 2007 67 13 6130 6135 (Pubitemid 47037493)
50. Iorio M. V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C. G., Alder H., Calin G. A., Ménard S., Croce C. M., MicroRNA signatures in human ovarian cancer Cancer Research 2007 67 18 8699 8707 (Pubitemid 47437445)
51. Lui W. O., Pourmand N., Patterson B. K., Fire A., Patterns of known and novel small RNAs in human cervical cancer Cancer Research 2007 67 13 6031 6043 (Pubitemid 47037482)
52. Takagi T., Iio A., Nakagawa Y., Naoe T., Tanigawa N., Akao Y., Decreased expression of microRNA-143 and-145 in human gastric cancers Oncology 2009 77 1 12 21
53. Chen X., Guo X., Zhang H., Xiang Y., Chen J., Yin Y., Cai X., Wang K., Wang G., Ba Y., Zhu L., Wang J., Yang R., Zhang Y., Ren Z., Zen K., Zhang J., Zhang C. Y., Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 2009 28 10 1385 1392
54. Akao Y., Nakagawa Y., Kitade Y., Kinoshita T., Naoe T., Downregulation of microRNAs-143 and -145 in B-cell malignancies Cancer Science 2007 98 12 1914 1920 (Pubitemid 350002197)
55. Wachtel M., Schfer B. W., Targets for cancer therapy in childhood sarcomas Cancer Treatment Reviews 2010 36 4 318 327
56. Song B., Wang Y., Xi Y., Kudo K., Bruheim S., Botchkina G. I., Gavin E., Wan Y., Formentini A., Kornmann M., Fodstad O., Ju J., Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells Oncogene 2009 28 46 4065 4074
57. Song B., Wang Y., Titmus M. A., Botchkina G., Formentini A., Kornmann M., Ju J., Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells Molecular Cancer 2010 9, article 96
58. Boni V., Bitarte N., Cristobal I., Zarate R., Rodriguez J., Maiello E., Garcia-Foncillas J., Bandres E., miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation Molecular Cancer Therapeutics 2010 9 8 2265 2275
59. Gougelet A., Pissaloux D., Besse A., Perez J., Duc A., Dutour A., Blay J.-Y., Alberti L., Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response International Journal of Cancer 2011 129 3 680 690
60. Vester B., Wengel J., LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA Biochemistry 2004 43 42 13233 13241 (Pubitemid 39391124)
61. Garzon R., Marcucci G., Croce C. M., Targeting microRNAs in cancer: rationale, strategies and challenges Nature Reviews Drug Discovery 2010 9 10 775 789
62. Ebert M. S., Neilson J. R., Sharp P. A., MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nature Methods 2007 4 9 721 726 (Pubitemid 47338166)
63. Choi W. Y., Giraldez A. J., Schier A. F., Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430 Science 2007 318 5848 271 274 (Pubitemid 47574854)
64. Pecot C. V., Calin G. A., Coleman R. L., Lopez-Berestein G., Sood A. K., RNA interference in the clinic: challenges and future directions Nature Reviews Cancer 2011 11 1 59 67
65. Pirollo K. F., Xu L., Chang E. H., Non-viral gene delivery for p53 Current Opinion in Molecular Therapeutics 2000 2 2 168 175 (Pubitemid 30212266)
66. Stegmeier F., Hu G., Rickles R. J., Hannon G. J., Elledge S. J., A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 37 13212 13217 (Pubitemid 41325003)
67. Takeshita F., Minakuchi Y., Nagahara S., Honma K., Sasaki H., Hirai K., Teratani T., Namatame N., Yamamoto Y., Hanai K., Kato T., Sano A., Ochiya T., Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo Proceedings of the National Academy of Sciences of the United States of America 2005 102 34 12177 12182 (Pubitemid 41291148)
68. Susa M., Iyer A. K., Ryu K., Choy E., Hornicek F. J., Mankin H., Milane L., Amiji M. M., Duan Z., Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma PLoS ONE 2010 5 5
69. Chen Y., Zhu X., Zhang X., Liu B., Huang L., Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy Molecular Therapy 2010 18 9 1650 1656